Cancer-related inflammation
Open accessThe DOI matches its Crossref record; 174 of the 175 references it cites were found in a registry or an index.
Abstract
The mediators and cellular effectors of inflammation are important constituents of the local environment of tumours. In some types of cancer, inflammatory conditions are present before a malignant change occurs. Conversely, in other types of cancer, an oncogenic change induces an inflammatory microenvironment that promotes the development of tumours. Regardless of its origin, 'smouldering' inflammation in the tumour microenvironment has many tumour-promoting effects. It aids in the proliferation and survival of malignant cells, promotes angiogenesis and metastasis, subverts adaptive immune responses, and alters responses to hormones and chemotherapeutic agents. The molecular pathways of this cancer-related inflammation are now being unravelled, resulting in the identification of new target molecules that could lead to improved diagnosis and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“many of these processes also occur in cancer as most of them are inflammation-related, including hypoxia-induced neovascularization, endothelial dysfunction, permeability of the microvasculature and the upregulation of adhesion molecules to facilitate the recruitment of cells30,31.”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the other hand, cytokine production can be triggered by oncogenic transformation, metabolic alteration, cell death, hypoxia, and the use of anti-cancer drugs (10).”
From Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis (2021) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Besides promoting cell proliferation, the action of cytokines in promoting cancer development includes antagonizing anti-tumor immune response, recruiting tumor-supportive stromal cells and immune-suppressive cells, inducing angiogenesis and metastasis, and altering the responses to therapeutic agents (10, 15)”
From Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis (2021) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Excessive or dysregulated inflammation is a major driver of tissue damage and the pathogenesis of numerous diseases, including stroke, Parkinson’s disease, atherosclerosis, and cancer [9,30,31,32,33].”
From Picroside II as a Potential Anti-Inflammatory Agent (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, rather than the dogma that oncogenesis is intrinsically triggered in pre-neoplastic cells, environmental factors, such as infection, stress, obesity, aging and smoking, each of which can induce chronic inflammation, could be a major cause of oncogenesis (4, 6, 9, 233).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [6]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746 · cited 1×
“jpg" NDATA ITEM> ]> Links between cancer and inflammation were first made in the nineteenth century, on the basis of observations that tumours often arose at sites of chronic inflammation and that inflammatory cells were present in biopsied samples from tumour”
Self-citationMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“TAMs and related cell types in mouse and human tumours generally have an M2 phenotype, which is oriented towards promoting tumour growth, remodelling tissues, promoting angiogenesis and suppressing adaptive immunity&hairsp”
Self-citationInvolvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · cited 1×
“This type of response might also contribute to successful chemotherapy or radiotherapy, according to recent data obtained by Lionel Apetoh and colleague”
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032 · cited 1×
“Cancer-related inflammation and adaptive immunity There is strong evidence from genetic studies of mouse models that cells of the adaptive immune system carry out surveillance and can eliminate nascent tumours (a process called immuno-editing”
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790 · cited 1×
“This transcription factor is constitutively activated both in tumour cells and in immune cells, and is involved in oncogenesis and inhibition of apoptosi”
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695 · cited 1×
“TAMs have been described as “obligate partners for tumour-cell migration, invasion and metastasis&rdquo”
Cited by
Items 701–800 of 1,085
Hart, M. J., Torres, S. J., McNaughton, S. A., & Milte, C. M. (2021) · Nutrition Journal · doi:10.1186/s12937-021-00674-9 · Cited by 188
“Inflammation of the endothelium has been associated with cardiovascular disease (CVD) and hypertension, and to the development of insulin resistance, type 2 diabetes (T2D) [2] and 15% of cancers [3], including bladder, oesophageal, prostate and thyroid [4].”
BackgroundThe prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer
Kang, M. H., Go, S.-I., Song, H.-N., Lee, A., Kim, S.-H., Kang, J.-H., Jeong, B.-K., Kang, K. M., Ling, H., & Lee, G.-W. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.317 · Cited by 199
“Lymphocytes have a crucial role in tumour defence by inducing cytotoxic cell death and inhibiting tumour cell proliferation and migration (Coussens and Werb, 2002; Mantovani et al, 2008).”
BackgroundNatural immunity to cancer in humans
Bindea, G., Mlecnik, B., Fridman, W.-H., Pagès, F., & Galon, J. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.02.006 · Cited by 192
Mesenchymal Cells in Colon Cancer
Koliaraki, V., Pallangyo, C. K., Greten, F. R., & Kollias, G. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.049 · Cited by 199
Kapinova, A., Kubatka, P., Golubnitschaja, O., Kello, M., Zubor, P., Solar, P., & Pec, M. (2018) · Environmental Health and Preventive Medicine · doi:10.1186/s12199-018-0724-1 · Cited by 195
“There is clear evidence that the immune system and inflammation play a critical role in the process of carcinogenesis and that inflammatory microenvironment is an essential component of all tumors [48].”
BackgroundImmunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy
Liu, Z., Zhou, Z., Dang, Q., Xu, H., Lv, J., Li, H., & Han, X. (2022) · Theranostics · doi:10.7150/thno.76854 · Cited by 189
Prins, B. P., Abbasi, A., Wong, A., Vaez, A., Nolte, I., Franceschini, N., Stuart, P. E., Guterriez Achury, J., Mistry, V., Bradfield, J. P., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1001976 · Cited by 199
“Emerging evidence suggests that persistent dysregulation of the inflammatory response is linked to a plethora of complex somatic and neuropsychiatric disorders [1–18].”
BackgroundMicroRNAs, new effectors and regulators of NF‐κB
Boldin, M. P., & Baltimore, D. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01089.x · Cited by 199
“Recent epidemiological and molecular research suggests that inflammation and cancer are intimately linked (120, 121).”
The Role of Complement in Tumor Growth
Pio, R., Corrales, L., & Lambris, J. D. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-5915-6_11 · Cited by 198
“Since then, a number of epidemiological studies have provided evidence that chronic infl ammation predisposes individuals to various types of cancer (Mantovani et al. 2008 ).”
BackgroundTumor microenvironment: a main actor in the metastasis process
Spano, D., & Zollo, M. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9457-5 · Cited by 194
The Role of Vitamin D in Cancer Prevention and Treatment
Krishnan, A. V., Trump, D. L., Johnson, C. S., & Feldman, D. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.02.011 · Cited by 194
CAFs and TAMs: maestros of the tumour microenvironment
Komohara, Y., & Takeya, M. (2017) · The Journal of Pathology · doi:10.1002/path.4824 · Cited by 197
“In turn, activated macrophages secrete a large number of molecules that influence tumour cells and other stromal cells [2-4].”
BackgroundBourgeois, D., Inquimbert, C., Ottolenghi, L., & Carrouel, F. (2019) · Microorganisms · doi:10.3390/microorganisms7100424 · Cited by 190
Miao, Z., Jiang, S., Ding, M., Sun, S., Ma, Y., Younis, M. R., He, G., Wang, J., Lin, J., Cao, Z., et al. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b05035 · Cited by 197
TGF-β-induced epithelial-mesenchymal transition: A link between cancer and inflammation
Fuxe, J., & Karlsson, M. C. I. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.05.004 · Cited by 198
Inflammaging and Cancer: A Challenge for the Mediterranean Diet
Ostan, R., Lanzarini, C., Pini, E., Scurti, M., Vianello, D., Bertarelli, C., Fabbri, C., Izzi, M., Palmas, G., Biondi, F., et al. (2015) · Nutrients · doi:10.3390/nu7042589 · Cited by 195
“models [13,15,17] along with the observation that preventive treatments with anti-inflammatory drugs such as aspirin or cyclooxygenase-2 (COX-2) inhibitors reduce the risk of developing colorectal and breast cancer and even mortality [15,18,19].”
BackgroundNakanishi, Y., Nakatsuji, M., Seno, H., Ishizu, S., Akitake-Kawano, R., Kanda, K., Ueo, T., Komekado, H., Kawada, M., Minami, M., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr128 · Cited by 190
Su, M.-J., Aldawsari, H., & Amiji, M. (2016) · Scientific Reports · doi:10.1038/srep30110 · Cited by 194
“Alternative activation to M2 macrophages comes in different varieties depending on the eliciting signals, including IL-4, IL-13, IL-10, and glucocorticoid hormones 15 .”
Tumor angiogenesis revisited: Regulators and clinical implications
Ronca, R., Benkheil, M., Mitola, S., Struyf, S., & Liekens, S. (2017) · Medicinal Research Reviews · doi:10.1002/med.21452 · Cited by 193
Mahajan, U. M., Langhoff, E., Goni, E., Costello, E., Greenhalf, W., Halloran, C., Ormanns, S., Kruger, S., Boeck, S., Ribback, S., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.009 · Cited by 192
Fu, J., Zhang, Z., Zhou, L., Qi, Z., Xing, S., Lv, J., Shi, J., Fu, B., Liu, Z., Zhang, J.-Y., et al. (2013) · Hepatology · doi:10.1002/hep.26054 · Cited by 192
SOCS, inflammation, and cancer
Inagaki-Ohara, K., Kondo, T., Ito, M., & Yoshimura, A. (2013) · JAK-STAT · doi:10.4161/jkst.24053 · Cited by 194
Cannon, N. A., Meyer, J., Iyengar, P., Ahn, C., Westover, K. D., Choy, H., & Timmerman, R. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000399 · Cited by 194
“The link between inflammation, particularly chronic inflammation, and cancer progression has been known for over a century.(3) Chronic inflammation has been shown to be associated with the induction of lung cancer and cancer in other organs.”
BackgroundZhou, S.-L., Dai, Z., Zhou, Z.-J., Chen, Q., Wang, Z., Xiao, Y.-S., Hu, Z.-Q., Huang, X.-Y., Yang, G.-H., Shi, Y.-H., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgt397 · Cited by 195
Occurrence and significance of tumor‐associated neutrophils in patients with colorectal cancer
Galdiero, M. R., Bianchi, P., Grizzi, F., Di Caro, G., Basso, G., Ponzetta, A., Bonavita, E., Barbagallo, M., Tartari, S., Polentarutti, N., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30076 · Cited by 192
“Discussion Inflammatory cells are an essential component of the tumor microenvironment.(5,6) In particular, cells of the monocytemacrophage lineage have been shown to promote angiogenesis, tissue remodeling, metastasis and suppression of adaptive immune responses.”
BackgroundSelf-citationHyperglycemia, tumorigenesis, and chronic inflammation
Chang, S.-C., & Yang, W.-C. V. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.11.003 · Cited by 187
Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy
Tahmasebi Birgani, M., & Carloni, V. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020405 · Cited by 193
“These phenotypically changes are called macrophage polarization [77].”
BackgroundTumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer
Mercogliano, M. F., Bruni, S., Elizalde, P. V., & Schillaci, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00584 · Cited by 177
“TNFα in Breast Cancer: Signaling, Progression, and Metastasis Low grade inflammation has a key role in cancer pathogenesis and progression [reviewed in (56, 57, 79)].”
BackgroundInfluentialNanobody: a promising toolkit for molecular imaging and disease therapy
Bao, G., Tang, M., Zhao, J., & Zhu, X. (2021) · EJNMMI Research · doi:10.1186/s13550-021-00750-5 · Cited by 185
Involvement of a Non-Human Sialic Acid in Human Cancer
Samraj, A. N., Läubli, H., Varki, N., & Varki, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00033 · Cited by 196
“Inflammation not only works as promoter during carcinogenesis (inflammation-induced cancer), but growing tumors that escaped immunosurveillance also induce an inflammatory response that can support cancer progression (cancer-related inflammation) (115, 122).”
BackgroundTu, B., Du, L., Fan, Q.-M., Tang, Z., & Tang, T.-T. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.06.006 · Cited by 196
Chronic inflammation and cancer: the role of the mitochondria.
Kamp, D. W., Shacter, E. B., & Weitzman, S. A. (2011) · PubMed · Cited by 243
Wang, R., Zhang, J., Chen, S., Lu, M., Luo, X., Yao, S., Liu, S., Qin, Y., & Chen, H. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.04.009 · Cited by 189
“[1] Mantovani A, Allavena P, Sica A, Balkwill F.”
BackgroundDmitrieva-Posocco, O., Dzutsev, A., Posocco, D. F., Hou, V., Yuan, W., Thovarai, V., Mufazalov, I. A., Gunzer, M., Shilovskiy, I. P., Khaitov, M. R., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.11.015 · Cited by 188
“Although chronic inflammation is a well-established driver in many cancers (Mantovani et al., 2008), inflammation also appears to play a deleterious role in cancers without overt underlying inflammatory etiologies.”
Novel 1,2,4-Oxadiazole Derivatives in Drug Discovery
Biernacki, K., Daśko, M., Ciupak, O., Kubiński, K., Rachon, J., & Demkowicz, S. (2020) · Pharmaceuticals · doi:10.3390/ph13060111 · Cited by 183
The Role of STAT3 in Non-Small Cell Lung Cancer
Harada, D., Takigawa, N., & Kiura, K. (2014) · Cancers · doi:10.3390/cancers6020708 · Cited by 190
“suggests a crucial role for STAT family proteins, especially STAT3, in selectively inducing and maintaining a pro-carcinogenic inflammatory microenvironment, both at the initiation of malignant transformation and during cancer progression [23–32].”
BackgroundMacrophage-Induced Tumor Angiogenesis Is Regulated by the TSC2–mTOR Pathway
Chen, W., Ma, T., Shen, X.-N., Xia, X.-F., Xu, G.-D., Bai, X.-L., & Liang, T.-B. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2684 · Cited by 189
“Introduction Inflammation and cancer are connected, as cancers arise at chronic inflammatory sites (1, 2), and inflammatory cells participate in processes of tumor progression such as neoangiogenesis.”
BackgroundCancer Chemoprevention and Nutri-Epigenetics: State of the Art and Future Challenges
Gerhauser, C. (2012) · Topics in Current Chemistry · doi:10.1007/128_2012_360 · Cited by 194
“mediators [256].”
BackgroundMeurman, J. H. (2010) · Journal of Oral Microbiology · doi:10.3402/jom.v2i0.5195 · Cited by 190
“Inflammation is a key feature in many chronic diseases including cancer (14, 15).”
BackgroundSanjeewa, K. K. A., Lee, J.-S., Kim, W.-S., & Jeon, Y.-J. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.09.005 · Cited by 192
Perisanidis, C., Psyrri, A., Cohen, E. E., Engelmann, J., Heinze, G., Perisanidis, B., Stift, A., Filipits, M., Kornek, G., & Nkenke, E. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.10.002 · Cited by 191
“It is now generally accepted that cross-talk exists between coagulation, the inflammatory response, and cancer development [1,64–70].”
BackgroundMicroRNAs in regulation of triple-negative breast cancer progression
Piasecka, D., Braun, M., Kordek, R., Sadej, R., & Romanska, H. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2689-2 · Cited by 185
Journal of Pharmaceutical and Biomedical Sciences
(2016) · Journal of Pharmaceutical and Biomedical Sciences · doi:10.20936/jpbms · Cited by 195
Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer
Iyengar, N. M., Zhou, X. K., Gucalp, A., Morris, P. G., Howe, L. R., Giri, D. D., Morrow, M., Wang, H., Pollak, M., Jones, L. W., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2239 · Cited by 187
“There is growing evidence that inflammation is a central mechanism through which obesity promotes cancer progression via local effects in the tumor microenvironment as well as systemic effects in the host (1-3, 7).”
BackgroundThe pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling
Bottazzi, B., Inforzato, A., Messa, M., Barbagallo, M., Magrini, E., Garlanda, C., & Mantovani, A. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.029 · Cited by 185
“prostatitis), is nowadays generally accepted [100].”
Self-citationVitamin D and the Skin: An Update for Dermatologists
Kechichian, E., & Ezzedine, K. (2018) · American Journal of Clinical Dermatology · doi:10.1007/s40257-017-0323-8 · Cited by 180
“Pre-existing local inflammation favors the occurrence and progression of cancer in the surrounding tissue [125], while”
Kangsamaksin, T., Chaithongyot, S., Wootthichairangsan, C., Hanchaina, R., Tangshewinsirikul, C., & Svasti, J. (2017) · PLOS ONE · doi:10.1371/journal.pone.0189628 · Cited by 190
NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer
Faria, S. S., Costantini, S., de Lima, V. C. C., de Andrade, V. P., Rialland, M., Cedric, R., Budillon, A., & Magalhães, K. G. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00724-8 · Cited by 186
Roles of the immune system in skin cancer
Rangwala, S., & Tsai, K. Y. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10507.x · Cited by 189
IL-17 Enhances Tumor Development in Carcinogen-Induced Skin Cancer
Wang, L., Yi, T., Zhang, W., Pardoll, D. M., & Yu, H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0775 · Cited by 185
“Epidemiologic studies identified chronic inflammation as a major risk factor for various types of cancer (1).”
Interplay between DNA repair and inflammation, and the link to cancer
Kidane, D., Chae, W. J., Czochor, J., Eckert, K. A., Glazer, P. M., Bothwell, A. L. M., & Sweasy, J. B. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.875514 · Cited by 186
“…(CRC) progression (Feagins et al., 2009; Thorsteinsdottir et al., 2011; Ullman & Itzkowitz, 2011), and several inflammatory pre-neoplastic states result in an increased risk of cancer progression in affected patients (Colotta et al., 2009; Grivennikov et al., 2010; Mantovani et al., 2008).”
BackgroundNecroptosis: an alternative cell death program defending against cancer
Chen, D., Yu, J., & Zhang, L. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.03.003 · Cited by 182
Caspase-1 cleaves PPARγ for potentiating the pro-tumor action of TAMs
Niu, Z., Shi, Q., Zhang, W., Shu, Y., Yang, N., Chen, B., Wang, Q., Zhao, X., Chen, J., Cheng, N., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00523-6 · Cited by 188
Tian, Y., Xu, Q., Sun, L., Ye, Y., & Ji, G. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.03.007 · Cited by 184
Askari, H., Rajani, S. F., Poorebrahim, M., Haghi-Aminjan, H., Raeis-Abdollahi, E., & Abdollahi, M. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.012 · Cited by 188
Hu, R., Saw, C. L.-L., Yu, R., & Kong, A.-N. T. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3276 · Cited by 187
On the cytokines produced by human neutrophils in tumors
Tecchio, C., Scapini, P., Pizzolo, G., & Cassatella, M. A. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.02.004 · Cited by 188
Xu, L., Kitade, H., Ni, Y., & Ota, T. (2015) · Biomolecules · doi:10.3390/biom5031563 · Cited by 185
“Obesity is a state of chronic low-grade systemic inflammation that contributes to the development of metabolic diseases such as type 2 diabetes mellitus (T2DM), nonalcoholic fatty liver disease (NAFLD), cardiovascular disease, and several types of cancer [1–4].”
Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy
Medler, T. R., Murugan, D., Horton, W., Kumar, S., Cotechini, T., Forsyth, A. M., Leyshock, P., Leitenberger, J. J., Kulesz-Martin, M., Margolin, A. A., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.09.003 · Cited by 188
“Because many of these characteristic features of tissue ‘‘damage’’ are also associated with chronic inflammation accompanying solid tumor development (Hanahan and Coussens, 2012; Hanahan and Weinberg, 2011; Mantovani et al., 2008), we hypothesized that complement components also functionally regulate aspects of de nov…”
Tumour-Associated Macrophages (TAMs) in Colon Cancer and How to Reeducate Them
Yahaya, M. A. F., Lila, M. A. M., Ismail, S., Zainol, M., & Afizan, N. A. R. N. M. (2019) · Journal of Immunology Research · doi:10.1155/2019/2368249 · Cited by 187
Lee, H. L., Jang, J. W., Lee, S. W., Yoo, S. H., Kwon, J. H., Nam, S. W., Bae, S. H., Choi, J. Y., Han, N. I., & Yoon, S. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-40078-8 · Cited by 183
Fest, J., Ruiter, R., Mulder, M., Groot Koerkamp, B., Ikram, M. A., Stricker, B. H., & van Eijck, C. H. J. (2020) · International Journal of Cancer · doi:10.1002/ijc.32303 · Cited by 183
Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation
Raisch, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i21.6560 · Cited by 173
Gu, L., Li, H., Chen, L., Ma, X., Li, X., Gao, Y., Zhang, Y., Xie, Y., & Zhang, X. (2016) · Oncotarget · doi:10.18632/oncotarget.7876 · Cited by 178
Yang, Y., Andersson, P., Hosaka, K., Zhang, Y., Cao, R., Iwamoto, H., Yang, X., Nakamura, M., Wang, J., Zhuang, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11385 · Cited by 186
Inflammatory signaling cascades and autophagy in cancer
Monkkonen, T., & Debnath, J. (2018) · Autophagy · doi:10.1080/15548627.2017.1345412 · Cited by 186
Geng, Y., Zhu, D., Wu, C., Wu, J., Wang, Q., Li, R., Jiang, J., & Wu, C. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.10.002 · Cited by 180
Cohort profile: ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden)
Ludvigsson, J. F., & Lashkariani, M. (2019) · Clinical Epidemiology · doi:10.2147/clep.s191914 · Cited by 184
FOXM1 (Forkhead box M1) in Tumorigenesis
(2013) · Advances in Cancer Research · doi:10.1016/b978-0-12-407190-2.00016-2 · Cited by 184
The Potential Role of Apigenin in Cancer Prevention and Treatment
Rahmani, A. H., Alsahli, M. A., Almatroudi, A., Almogbel, M. A., Khan, A. A., Anwar, S., & Almatroodi, S. A. (2022) · Molecules · doi:10.3390/molecules27186051 · Cited by 170
“Inflammation is one of the foremost features to endorse the progression of tumor, increases cancer risk [35].”
BackgroundThe tumor microenvironment in hepatocellular carcinoma (Review)
Libra, M. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1408 · Cited by 187
Anson, M., Crain-Denoyelle, A.-M., Baud, V., Chereau, F., Gougelet, A., Terris, B., Yamagoe, S., Colnot, S., Viguier, M., Perret, C., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci43937 · Cited by 179
Ricciardi, M., Zanotto, M., Malpeli, G., Bassi, G., Perbellini, O., Chilosi, M., Bifari, F., & Krampera, M. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.29 · Cited by 182
“Again, EMT-like morphological changes, E-cadherin protein loss and vimentin upregulation were confirmed by in situ immunofluorescence (Figure 1B, right panel).”
BackgroundInfluentialStorci, G., Sansone, P., Mari, S., D'Uva, G., Tavolari, S., Guarnieri, T., Taffurelli, M., Ceccarelli, C., Santini, D., Chieco, P., et al. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22264 · Cited by 189
“DOI: 10.1002/jcp.22264 Over the past decade, it has become increasingly clear that inflammation plays a major role in cancer pathogenesis (Mantovani et al., 2008).”
BackgroundInfluentialMacrophage polarization to a unique phenotype driven by B cells
Wong, S., Puaux, A., Chittezhath, M., Shalova, I., Kajiji, T. S., Wang, X., Abastado, J., Lam, K., & Biswas, S. K. (2010) · European Journal of Immunology · doi:10.1002/eji.200940288 · Cited by 184
The biology of depression in cancer and the relationship between depression and cancer progression
Sotelo, J. L., Musselman, D., & Nemeroff, C. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.875891 · Cited by 179
“Infl ammation has been linked to 15 – 20% of all deaths from cancer worldwide (Mantovani et al., 2008).”
BackgroundOrai1 and CRAC Channel Dependence of VEGF-Activated Ca 2+ Entry and Endothelial Tube Formation
Li, J., Cubbon, R. M., Wilson, L. A., Amer, M. S., McKeown, L., Hou, B., Majeed, Y., Tumova, S., Seymour, V. A. L., Taylor, H., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.243352 · Cited by 183
De Palma, M., & Hanahan, D. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.01.011 · Cited by 183
Conversion of Stem Cells to Cancer Stem Cells: Undercurrent of Cancer Initiation
Afify, S. M., & Seno, M. (2019) · Cancers · doi:10.3390/cancers11030345 · Cited by 182
“What is the functional role of the leukocytes in the tumor observed by Virchow? Are they promoting tumors in place of self-protecting or wound healing? Although the link between inflammation and cancer is now largely accepted [47], the exact mechanism is not clear yet.”
BackgroundMedicinal uses, phytochemistry and pharmacology of the genus Uncaria
Zhang, Q., Zhao, J. J., Xu, J., Feng, F., & Qu, W. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.06.011 · Cited by 185
Assessing cell and organ senescence biomarkers
de Jesus, B. B., & Blasco, M. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.247866 · Cited by 187
Ilie, M., Hofman, V., Ortholan, C., Bonnetaud, C., Coëlle, C., Mouroux, J., & Hofman, P. (2012) · Cancer · doi:10.1002/cncr.26456 · Cited by 179
“Large cell carcinoma 29 (4) 16 (55) 13 (45) 21 (72) 8 (28) 20 (69) 9 (31)”
Tumor microenvironment: Bone marrow-mesenchymal stem cells as key players
Barcellos-de-Souza, P., Gori, V., Bambi, F., & Chiarugi, P. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.10.004 · Cited by 180
“In the tumor microenvironment, cancerassociated macrophages (CAM) represent the major inflammatory component, and clinical observations indicate that the CAM mainly show an M2 phenotype polarization [114].”
BackgroundSzkandera, J., Stotz, M., Absenger, G., Stojakovic, T., Samonigg, H., Kornprat, P., Schaberl-Moser, R., AlZoughbi, W., Lackner, C., Ress, A. L., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.701 · Cited by 189
Stromal Macrophage Expressing CD204 is Associated with Tumor Aggressiveness in Lung Adenocarcinoma
Ohtaki, Y., Ishii, G., Nagai, K., Ashimine, S., Kuwata, T., Hishida, T., Nishimura, M., Yoshida, J., Takeyoshi, I., & Ochiai, A. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181eba692 · Cited by 185
Cell membrane-covered nanoparticles as biomaterials
Xuan, M., Shao, J., & Li, J. (2019) · National Science Review · doi:10.1093/nsr/nwz037 · Cited by 182
Cellular senescence and the tumour microenvironment
Takasugi, M., Yoshida, Y., & Ohtani, N. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13268 · Cited by 172
Cao, Y., Li, P., Zhang, Y., Qiu, M., Li, J., Ma, S., Yan, Y., Li, Y., & Han, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1087345 · Cited by 182
“Lymphocytes exert protective effects by inducing cytotoxic cell death and inhibiting tumor cell proliferation and migration (47).”
BackgroundImmune Infiltration and Prostate Cancer
Strasner, A., & Karin, M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00128 · Cited by 184
“A relationship between inflammation and cancer was first proposed by Virchow in 1863 (18) and chronic inflammation is now well accepted as a driving force behind many malignancies, such as gastric, colon, esophageal and lung cancers, and hepatocellular carcinoma (19).”
BackgroundSong, X., Gao, H., Lin, Y., Yao, Y., Zhu, S., Wang, J., Liu, Y., Yao, X., Meng, G., Shen, N., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.11.018 · Cited by 185
“Recent studies have demonstrated that inflammation promotes the development of a variety of cancers, including colitis-associated cancer (CAC) (Grivennikov, 2013; Mantovani et al., 2008).”
BackgroundMeng, Y., Beckett, M. A., Liang, H., Mauceri, H. J., van Rooijen, N., Cohen, K. S., & Weichselbaum, R. R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2995 · Cited by 181
Soy and Breast Cancer: Focus on Angiogenesis
Varinska, L., Gal, P., Mojzisova, G., Mirossay, L., & Mojzis, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160511728 · Cited by 186
“It aids in the growth and survival of malignant cells, stimulates angiogenesis and suppresses adaptive immune responses [122,123].”
BackgroundInflammation and cancer: What a surgical oncologist should know
Dupré, A., & Malik, H. Z. (2018) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2018.02.209 · Cited by 182
Georgescu, S. R., Mitran, C. I., Mitran, M. I., Caruntu, C., Sarbu, M. I., Matei, C., Nicolae, I., Tocut, S. M., Popa, M. I., & Tampa, M. (2018) · Journal of Immunology Research · doi:10.1155/2018/5315816 · Cited by 174
Hollmén, M., Karaman, S., Schwager, S., Lisibach, A., Christiansen, A. J., Maksimow, M., Varga, Z., Jalkanen, S., & Detmar, M. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1115177 · Cited by 185
“growth and metastasis supporting signals as well as aiding immune escape from the host.(4) These tumor-supporting”
BackgroundHelicobacter pylori Infection and Gastric Adenocarcinoma.
Correa, P., & Piazuelo, M. B. (2011) · PubMed · Cited by 238
Viers, B. R., Boorjian, S. A., Frank, I., Tarrell, R. F., Thapa, P., Karnes, R. J., Thompson, R. H., & Tollefson, M. K. (2014) · European Urology · doi:10.1016/j.eururo.2014.02.042 · Cited by 181
Mast Cells: Potential Positive and Negative Roles in Tumor Biology
Marichal, T., Tsai, M., & Galli, S. J. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0119 · Cited by 185
RAS-mediated oncogenic signaling pathways in human malignancies
Khan, A. Q., Kuttikrishnan, S., Siveen, K. S., Prabhu, K. S., Shanmugakonar, M., Al- Naemi, H. A., Haris, M., Dermime, S., & Uddin, S. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.03.001 · Cited by 179
Thyroid autoimmune disorders and cancer
Ferrari, S. M., Fallahi, P., Elia, G., Ragusa, F., Ruffilli, I., Paparo, S. R., & Antonelli, A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.05.019 · Cited by 177
Metadata
- Authors
- Mantovani, A., Allavena, P., Sica, A., & Balkwill, F.
- Affiliations
- IRCCS Humanitas Research Hospital (IT)
- Fondazione Humanitas per la Ricerca (IT)
- Queen Mary University of London (GB)
- Venue
- Nature
- Published
- 2008-07-01
- Volume
- 454
- Issue
- 7203
- Pages
- 436-444
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2123105952
- Semantic Scholar
- b3a9e344a32ad6ca402d9149ac74b2b1df9e3076
- Cited by
- 11,399
- References
- 175
- Citations by year
- 2026: 419 · 2025: 554 · 2024: 655 · 2023: 761 · 2022: 848 · 2021: 878 · 2020: 864 · 2019: 759 · 2018: 752 · 2017: 732 · 2016: 692 · 2015: 683 · 2014: 643 · 2013: 574 · 2012: 510
- FWCI
- 26.32
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Funders
- Cancer Research UK
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- tumor inflammation, tumor microenvironment, inflammatory mediators, angiogenesis, metastasis, immune evasion, chemoresistance, endocrine response, inflammatory signaling, therapeutic target
- MeSH terms
- Humans, Inflammation, Leukocytes, Neoplasm Invasiveness, Neoplasms, Oncogenes, Gonadal Steroid Hormones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.